- Kapoor J, Pramanik SK, Agrawal P, Khushoo V, Naim F, Mirgh SP, et al. Retrospective institutional analysis of fludarabine/8 Gy TBI reduced intensity conditioning in high risk ALL. Bone Marrow Transplant. 2020 Apr 14
|
- Bhurani D, Kapoor J, Yadav N, Khushoo V, Agrawal N, Ahmed R, et al. Experience with combination of hydroxyurea and low-dose thalidomide in transfusion-dependent beta thalassemia patients. Ann Hematol. 2021 Jun 1;100(6):1417–27.
|
- Mehta DMP, Khushoo V. Is Old (Fludrabine/Busulfan/Cyclophosphamide/ rAntiThymocyteGlobulin) Conditioning Still Gold for Allogeneic Transplants in Transfusion Dependent Beta-Thalassemia of All Risk Categories in 21st Century? Indian J Hematol Blood Transfus. 2023 Apr 3:1-9. doi: 10.1007/s12288-023-01646-1. Epub ahead of print. PMID: 37362406; PMCID: PMC10068721
|
- Mehta P, Yadav N, Folbs B, Kapoor J, Khushoo V, Agrawal N, et al. Retrospective Study of Carfilzomib-Pomalidomide-Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients in a Tertiary Care Hospital in India. Indian J Hematol Blood Transfus [Internet]. 2021 Jul 3
|
- Sharma A, Ahmed R, Agrawal N, Kapoor J, Sharma A, Khushoo V, et al. Primary Bone Lymphoma: A 13 Year Retrospective Institutional Analysis in the Chemo-Immunotherapy Era. Indian J Hematol Blood Transfus. 2021 Apr 1;37(2):240–8.
|